| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.0053 | 1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0014 | 1 |